Insulin-Like Growth Factor-1 (IGF-1), Serum

Specimen requirement Adult patient:

 4 mL clotted blood in Becton Dickinson (BD) brand red-top vacutainer (labelled 'IGF-1 only')

Minimum blood volume: 4 mL

Paediatric patient:

1 mL clotted blood in BD brand red-top microtainer

Number of vials: 2

Minimum blood volume: 2 mL

Authorisation code required No
24 Hr available service No
Method Liquid chromatography-time-of-flight-mass spectrometry
Reference interval

 

(Unit: µg/L)

 

Age (Year)

Male

Female

< 1

16 - 142

17 - 185

1 - 1.9

16 - 134

16 - 175

2 - 2.9

16 - 135

16 - 178

3 - 3.9

30 - 155

38 - 214

4 - 4.9

28 - 181

34 - 238

5 - 5.9

31 - 214

37 - 272

6 - 6.9

38 - 253

45 - 316

7 - 7.9

48 - 298

58 - 367

8 - 8.9

62 - 347

76 - 424

9 - 9.9

80 - 398

99 - 483

10 - 10.9

100 - 449

125 - 541

11 - 11.9

123 - 497

152 - 593

12 - 12.9

146 - 541

178 - 636

13 - 13.9

168 - 576

200 - 664

14 - 14.9

187 - 599

214 - 673

15 - 15.9

201 - 609

218 - 659

16 - 16.9

209 - 602

208 - 619

17 - 17.9

207 - 576

185 - 551

18 - 19.9

108 - 548

108 - 548

20 - 24.9

83 - 456

83 - 456

25 - 29.9

63 - 373

63 - 373

30 - 39.9

53 - 331

53 - 331

40 - 49.9

52 - 328

52 - 328

50 - 59.9

50 - 317

50 - 317

60 - 69.9

41 - 279

41 - 279

70 - 79.9

34 - 245

34 - 245

80 and above

34 - 246

34 - 246

 

(Source: 
Reference interval of IGF-I, LC-MS, was adopted from Quest Diagnostics laboratory report, 2015)

Clinical indication

Diagnosis of acromegaly or gigantism.

Evaluation, monitoring and follow-up of growth hormone deficiency or excess in children and adults.

Result interpretation

It is important to note that IGF-I levels vary with age and must be interpreted with this in mind. The levels are lower in children and elderly than adults, and show a marked pubertal rise.

Levels are increased in acromegaly, and the test is used in the initial assessment of patients with appropriate symptoms or signs, prior to a growth hormone suppression test. The test may also be of value in monitoring the response to treatment of growth hormone excess. Increased level of IGF-I is also observed in pregnancy.

IGF-I level is reduced in GH deficiency or GH resistance. These conditions result in short stature if acquired in childhood. Reduced level of IGF-I is also observed in patients with anorexia, nutritional deficiency, liver disease and hypothyroidism.

Measurement of uncertainty See table.
Frequency of measurement 1 - 2 weeks